Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Total Liabilities (2020 - 2026)

Invivyd's (IVVD) quarterly Total Liabilities came in at $37.8 million in Q2 2026, down 18.44% on a YoY basis from $46.3 million in Q2 2025, and up 6.96% quarter-over-quarter from $35.3 million in Q4 2025.

Analysis

Invivyd (IVVD) Total Liabilities (2020 - 2026) Analysis & Trends

Invivyd (IVVD) has reported Total Liabilities for 7 consecutive years, with $37.8 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Liabilities fell 18.44% year-over-year to $37.8 million; the trailing twelve-month figure through Jun 2026 stood at $37.8 million (down 18.44% YoY), and the FY2025 full-year result was $35.3 million, down 42.97% from the prior year.
  • Total Liabilities advanced to $37.8 million in Q2 2026 per IVVD's latest filing, from $35.3 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $96.9 million in Q1 2022 and bottomed at $23.8 million in Q1 2023.
  • Historically, Total Liabilities has averaged $47.6 million across 5 years, with a median of $46.1 million in 2025.
  • The sharpest annual moves came in 2023 and 2024: Total Liabilities tumbled 75.42% in 2023, then jumped 177.15% in 2024.
  • Over 5 years, Total Liabilities stood at $27.2 million in 2022, then jumped by 90.14% to $51.7 million in 2023, then advanced by 19.85% to $62.0 million in 2024, then tumbled by 42.97% to $35.3 million in 2025, then advanced by 6.96% to $37.8 million in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods registered $37.8 million, $35.3 million, and $46.1 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 83.95 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 37.53 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 7.18 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 10.02 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 1.62 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 4.20 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 4.20 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 13.24 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 1.35 Bn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn 37.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37.80 Mn
Dec 31, 2025 35.34 Mn
Sep 30, 2025 46.09 Mn
Jun 30, 2025 46.35 Mn
Mar 31, 2025 49.60 Mn
Dec 31, 2024 61.98 Mn
Sep 30, 2024 78.76 Mn
Jun 30, 2024 36.70 Mn
Mar 31, 2024 36.97 Mn
Dec 31, 2023 51.71 Mn
Sep 30, 2023 28.42 Mn
Jun 30, 2023 33.85 Mn
Mar 31, 2023 23.82 Mn
Dec 31, 2022 27.20 Mn
Sep 30, 2022 47.30 Mn
Jun 30, 2022 69.77 Mn
Mar 31, 2022 96.88 Mn
Dec 31, 2021 62.07 Mn
Sep 30, 2021 53.06 Mn
Jun 30, 2021 37.91 Mn